Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • friendlypelican
    Junior Member
    • Apr 2016
    • 1

    #1

    DEseq no significant genes

    Hi everyone,

    I'm very new to the world of RNA-seq so forgive me for my lack of knowledge.

    I got some RNA-seq data from my control cells and treated cells, with 3 replicates of each. The company that did the sequencing provided a bunch of BAM files from aligning the data to the mouse genome with TopHat.

    It was suggested to me that I should use DEseq to analysis the data and thanks to the vignette, I've managed it! (i think).

    My current problem is that when I'm looking at the logfold changes, they are all very very small, like less than 0.5 both sides although the adjusted p value suggests that they are significant. The only thing I can think of is that it might be due to variation between the samples which i believe can be identified from the plotPCA function, although I'm not entirely clear how to interpret it. I've attached the output.

    I'm at a bit of a loss on what to do next, is there a way to lower the stringency of the analysis? or should i just look at the 0.5 fold changes?

    Any help would be greatly appreciated.
    Attached Files

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...